Abstract PO1-04-12: Palbociclib Versus Ribociclib in First-Line Treatment of Patients with Hormone-Receptor Positive HER2 Negative Advanced Breast Cancer – Real World Outcome Data from the German Registry Platform OPAL
Cancer Research（2024）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined